Retour
48
27
Également cotée sous
FLMNY
OTC
Fourchette du Jour
52,85 €
52,90 €
Fourchette 52 Semaines
42,54 €
64,00 €
Volume
200
Moyenne 50J / 200J
57,63 €
/
60,50 €
Clôture Précédente
52,85 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 29,2 | 0,2 |
| P/B | 4,9 | 3,0 |
| ROE % | 18,0 | 3,6 |
| Net Margin % | 6,7 | 3,8 |
| Rev Growth 5Y % | 12,2 | 10,0 |
| D/E | 1,0 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
3,50 €
3,41 € – 3,57 €
|
2,93B | 6 |
| FY2028 |
3,34 €
3,26 € – 3,41 €
|
2,86B | 7 |
| FY2027 |
3,00 €
2,93 € – 3,07 €
|
2,71B | 6 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-11-06 | N/A | 0,73 € | — |
| 2025-08-28 | N/A | 0,73 € | — |
| 2025-04-28 | N/A | 0,68 € | — |
| 2025-02-26 | N/A | 0,33 € | — |
| 2024-11-01 | 0,70 € | 0,47 € | -32,9% |
| 2024-08-29 | 1,55 € | 0,14 € | -91,0% |
| 2024-04-30 | 1,55 € | 0,14 € | -91,0% |
| 2024-02-29 | 1,55 € | 0,14 € | -91,0% |
Dividend History
6 yr streakYield
0,02%
Payout Ratio
0,55%
Growth (3Y)
-8,48%
Growth (5Y)
-9,55%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Jul 13, 2026 | Jul 14, 2026 | 1,20 € | 2,27% |
| Jul 11, 2025 | Jul 15, 2025 | 1,35 € | 2,10% |
| Jul 12, 2024 | Jul 16, 2024 | 1,17 € | 2,44% |
| Jul 14, 2023 | Jul 18, 2023 | 0,88 € | 1,61% |
| Jul 15, 2022 | Jul 19, 2022 | 1,76 € | 3,25% |
| Jul 09, 2021 | Jul 13, 2021 | 1,40 € | 1,61% |
| Jul 12, 2019 | Jul 16, 2019 | 2,22 € | 2,99% |
| Jul 13, 2018 | Jul 17, 2018 | 2,17 € | 2,61% |
| Jun 02, 2017 | Jun 07, 2017 | 2,11 € | 2,66% |
| Jul 15, 2016 | — | 2,05 € | 3,10% |
| Jul 10, 2015 | — | 1,87 € | 2,83% |
| Jul 03, 2014 | — | 6,79 € | 3,23% |
Points Clés
Revenue grew 12,19% annually over 5 years — strong growth
Earnings grew 21,90% over the past year
ROE of 17,99% — decent returns on equity
Generating 327,41M in free cash flow
Cash machine — converts 215,25% of earnings into free cash flow
Capital efficient — spends only 3,65% of revenue on capex
Croissance
Revenue Growth (5Y)
12,19%
Revenue (1Y)14,98%
Earnings (1Y)21,90%
FCF Growth (3Y)33,87%
Qualité
Return on Equity
17,99%
ROIC14,45%
Net Margin6,72%
Op. Margin15,09%
Sécurité
Debt / Equity
0,97
Current Ratio0,64
Interest Coverage8,16
Valorisation
P/E Ratio
29,18
Forward P/E19,58
P/B Ratio4,94
EV/EBITDA15,27
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 14,98% | Revenue Growth (3Y) | 13,44% |
| Earnings Growth (1Y) | 21,90% | Earnings Growth (3Y) | 21,14% |
| Revenue Growth (5Y) | 12,19% | Earnings Growth (5Y) | 6,92% |
| Profitability | |||
| Revenue (TTM) | 2,26B | Net Income (TTM) | 152,11M |
| ROE | 17,99% | ROA | 6,42% |
| Gross Margin | 80,02% | Operating Margin | 15,09% |
| Net Margin | 6,72% | Free Cash Flow (TTM) | 327,41M |
| ROIC | 14,45% | FCF Growth (3Y) | 33,87% |
| Safety | |||
| Debt / Equity | 0,97 | Current Ratio | 0,64 |
| Interest Coverage | 8,16 | ||
| Dividends | |||
| Dividend Yield | 0,02% | Payout Ratio | 0,55% |
| Dividend Growth (3Y) | -8,48% | Dividend Growth (5Y) | -9,55% |
| Consecutive Div Years | 6 yrs | ||
| Valuation | |||
| P/E Ratio | 29,18 | Forward P/E | 19,58 |
| P/B Ratio | 4,94 | P/S Ratio | 1,96 |
| PEG Ratio | 1,06 | Forward PEG | N/A |
| EV/EBITDA | 15,27 | Fwd EV/EBITDA | 10,03 |
| Forward P/S | 1,73 | Fwd Earnings Yield | 5,11% |
| FCF Yield | 7,38% | ||
| Market Cap | 4,44B | Enterprise Value | 5,22B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 2,26B | 1,97B | 1,76B | 1,68B | 1,43B |
| Net Income | 152,11M | 124,79M | 103,66M | 136,86M | 116,41M |
| EPS (Diluted) | 1,81 | 1,49 | 1,23 | 1,63 | 1,39 |
| Gross Profit | 1,81B | 1,57B | 1,38B | 1,34B | 1,15B |
| Operating Income | 341,68M | 648,84M | 575,63M | 583,61M | 179,23M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 2,37B | 2,02B | 1,77B | 1,74B | 1,67B |
| Total Liabilities | 1,46B | 1,06B | 913,48M | 863,09M | 832,86M |
| Shareholders' Equity | 899,13M | 792,03M | 804,22M | 819,83M | 779,20M |
| Total Debt | 873,85M | 592,15M | 505,66M | 458,26M | 425,72M |
| Cash & Equivalents | 94,29M | 58,93M | 51,25M | 174,89M | 103,72M |
| Current Assets | 545,62M | 510,40M | 489,95M | 538,32M | 518,18M |
| Current Liabilities | 846,71M | 529,51M | 391,79M | 366,29M | 356,30M |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#442 of 1049
Custom
Balanced Risk
#145 of 153
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Balanced Risk
Mar 24, 2026